|
|
|
|
|
|
| Open:
|
2.51 |
|
Volume:
|
21 |
| High:
|
2.51 |
|
52Wk High:
|
5.21 |
| Low:
|
2.40 |
|
52Wk Low:
|
2.05 |
|
|
|
|
|
|
|
|
|
|
|
7000 Broadway
Denver, CO 80221, US
|
|
Laboratory Analytical Instruments |
| |
|
|
|
 |
 |
|
 |
|
Free Registration enables all site features including Email Alerts, RSS Feeds, Charts & Reports, SEC Filings, and Executive & Company Profiles.
|
 |
 |
 |
 |
|
|
 |
|
 |
|
|
|
|
Board Member Report includes all current and historical board members, their board committees, whether they are the chair of each committee, the date they became a member of the board and their Job Title if they are also an executive of the firm. Also, you can create an email alert for any board member right from the Board Member report!
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEC filings are made available through
SECFilings.com – our free SEC filings portal with e-mail alert
and RSS capabilities. Clicking on the links to the left will bring you to the
corresponding page on SECFilings.com where you can login with your
ExecutiveDisclosure.com username and password to instantly view filings and
setup e-mail or RSS alerts.
|
|
 |
 |
 |
|
|
|
|
Company Average Compensation vs. Average Compensation for all Same Market Cap Companies in Same Industry chart compares the average pay for the company against all companies in the same industry and market cap using actual dollar figures.
|
|
|
|
|
|
 |
|
 |
|
|
 |
|
|
|
|
Company Average Compensation vs. Industry Average Compensation chart compares the average pay for the company against all companies in the same industry using actual dollar figures, making it easy to see how the current company's compensation practices compare against the industry average.
|
|
|
|
|
|
|
|
|
|
|
|
Company Average Compensation % Trend vs. Company Stock Prices % Trend chart compares the year over year percentage change in the average compensation package against the year over year percentage change in the company's stock price.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| David Howson became the President of the Company in April 2004. Previously Mr. Howson was a consultant to the Company and had acted as the Director for Business Development since January 2001. Mr. Howson is responsible for coordinating business plan... (Read
more) |
|
04/2004
150000.00 |
|
|
|
|
| |
|
|
|
|
| Jeffrey D. Shafer Ph.D. has been a Senior Research Bio-Informatics Scientist since September 9, 2006. Dr Shafer was previously employed as a Senior Performance Analyst at Sun Microsystems from 2003-2006. At Sun Microsystems he developed and... (Read
more) |
|
|
|
|
|
|
| |
|
|
|
|
| Ms. Blue, age 51, served as a staff accountant from August 2006 to January 2007 with Harper Lutz Zuber Potenza & Associates, LLC, a Certified Public Accounting firm located in Denver. From October 2000 to August 2006, Ms. Blue was self employed in... (Read
more) |
|
02/16/2007
|
|
|
|
|
| |
|
|
|
|
| On August 24, 2007, the Corporation appointed Bruce H. McDonald as the principal accounting officer. Bruce H. McDonald, age 57, has served as the principal of and a certified public accountant for McDonald & Associates, P.C. from 1985 to the... (Read
more) |
|
08/24/2007
|
|
|
|
|
| |
|
|
|
|
| Ken Emoto Ph.D. has been a Senior Scientist with Accelr8 since June 2004. From 2001 through 2003, Mr. Emoto contributed to three projects for the delivery of small to large drug molecules utilizing polymers at Nektar Therapeutics. Mr. Emoto earned... (Read
more) |
|
|
|
|
|
|
| |
|
|
|
|
| Alexander Arnold III, 67, has served as a director of the Company since September 1992. For the past 30 years Mr. Arnold has served as a Managing Director of Trainer, Wortham & Co., Inc., a New York City-based investment counseling firm. Mr. Arnold... (Read
more) |
|
09/1992
|
|
|
|
|
| |
|
|
|
|
| Charles E. Gerretson, 62, was appointed a director of the Company on July 19, 2003. For the past 30 years, Mr. Gerretson has served as the President of Gerretson Realty, Inc., a Denver Colorado based real estate firm, which Mr. Gerretson founded.... (Read
more) |
|
07/19/2003
|
|
|
|
|
| |
|
|
|
|
| Charles Greef, Ph.D. has been a Senior Scientist with the Company since May 2003. Dr. Greef received his Doctorate in Chemistry from the University of Colorado at Boulder under the direction of Professor Marvin Caruthers, studying synthesis and... (Read
more) |
|
05/2003
|
|
|
|
|
| |
|
|
|
|
| Michael J. Lochhead, Ph.D. has been a Senior Scientist with Accelr8 since April 2001. Dr. Lochhead is responsible for product design and development. From 1998 through 2001, Dr. Lochhead was an Assistant Professor of Chemical Engineering at the... (Read
more) |
|
|
|
|
|
|
| |
|
|
|
|
| Steven W. Metzger has been a Research Scientist with the Company since April 2001, and is now a Senior Scientist. From 2000 through 2001, Mr. Metzger was responsible for the implementation of merging core technologies at Heska Corporation. He was... (Read
more) |
|
|
|
|
|
|
| |
|
|
|
|
| Thomas V. Geimer, 61, has been the Chairman of the Board of Directors and a director of Accelr8 since 1987. He currently serves as the Chief Executive Officer, Chief Financial Officer and Secretary of the Company. Mr. Geimer is responsible for... (Read
more) |
|
1987
165000.00 |
|
|
|
|
|
|
|
|